Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Cheng-shi Xu"'
Publikováno v:
Chinese Medical Journal, Iss 6, Pp 650-656 (2020)
Abstract. Background. Intravertebral and general anesthesia (GA) are two main anesthesia approaches but both have defects. This study was aimed to evaluate the effect of subarachnoid anesthesia combined with propofol target-controlled infusion (TCI)
Externí odkaz:
https://doaj.org/article/ec3cb6eaa5ce4122905639ae26ed5268
Publikováno v:
Current Medical Science. 43:336-343
Autor:
Yu-Hang Zhao, Ze-Fen Wang, Chang-Jun Cao, Hong Weng, Cheng-Shi Xu, Kai Li, Jie-Li Li, Jing Lan, Xian-Tao Zeng, Zhi-Qiang Li
Publikováno v:
Frontiers in Neurology, Vol 9 (2018)
Background and objectivePromoter status of O6-methylguanine-DNA methyltransferase (MGMT) has been widely established as a clinically relevant factor in glioblastoma (GBM) patients. However, in addition to varied therapy schedule, the prognosis of GBM
Externí odkaz:
https://doaj.org/article/a3a5d48ee95d40f28335b6ab950949dc
Publikováno v:
Glioma, Vol 4, Iss 1, Pp 5-11 (2021)
Background and Aim: Many studies have demonstrated the value of neuronavigation guided by fluorescence staining for treating glioma patients. Here, we compared the rate of overall survival (OS) and the extent of tumor resection among patients who und
Autor:
Cheng⁃shi XU, Yun YUE
Publikováno v:
Chinese Journal of Contemporary Neurology and Neurosurgery, Vol 10, Iss 4, Pp 430-435 (2010)
DOI:10.3969/j.issn.1672-6731.2010.04.009
Externí odkaz:
https://doaj.org/article/048059e97a574fddb352a13898ec4e30
Autor:
Jie Li, Cheng-Shi Xu, Su-Fang Tian, Ze-Fen Wang, Yu-Hang Zhao, Yan-Bing Cheng, Zhi-Qiang Li, Kai Li, Yu-Xiang Cai
Publikováno v:
CNS Neuroscience & Therapeutics
Aims Secondary gliosarcoma (SGS) rarely arises post treatment of primary glioblastoma multiforme (GBM), and contains gliomatous and sarcomatous components. The origin and clonal evolution of SGS sarcomatous components remain uncharacterized. Therapeu
Autor:
Cheng-Shi Xu1 xucs1985@163.com, Ze-Fen Wang2 wangzf@whu.edu.cn, Li-Ming Dai1 tate-dai@163.com, Sheng-Hua Chu3 shenghuachu@163.com, Ling-Ling Gong4 624964417@qq.com, Ming-Huan Yang1 ymh3116@163.com, Zhi-Qiang Li1,5 lizhiqiang@whu.edu.cn
Publikováno v:
Journal of Translational Medicine. 2014, Vol. 12 Issue 1, p1-24. 24p.
Autor:
Cheng-Shi Xu1, Ze-Fen Wang2, Xiao-Dong Huang1,3, Li-Ming Dai1, Chang-Jun Cao1, Zhi-Qiang Li1,4 lizhiqiang@whu.edu.cn
Publikováno v:
Journal of Translational Medicine. 2015, Vol. 13 Issue 1, p1-11. 11p.
Publikováno v:
Glioma, Vol 3, Iss 3, Pp 119-125 (2020)
As theories evolve, the mechanism of glioma origination remains poorly understood. Understanding this mechanism promotes the clinical research on glioma therapeutic strategy and then improves the prognosis of patients with glioma. However, the overal
Autor:
Chang-Jun Cao, Jie-Li Li, Jing Lan, Yu-Hang Zhao, Kai Li, Zhi-Qiang Li, Xian-Tao Zeng, Ze-Fen Wang, Cheng-Shi Xu, Hong Weng
Publikováno v:
Frontiers in Neurology
Frontiers in Neurology, Vol 9 (2018)
Frontiers in Neurology, Vol 9 (2018)
Background and objective Promoter status of O6-methylguanine-DNA methyltransferase (MGMT) has been widely established as a clinically relevant factor in glioblastoma (GBM) patients. However, in addition to varied therapy schedule, the prognosis of GB